Patients with dyslipidemia can be treated with a variety of agents, depending on their particular abnormality. Agents include statin drugs, fibrates, prescription-strength omega-3 fatty acids, niacin, ...

Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — In treating adults with prediabetes or type 2 diabetes, clinicians must consider and work to ...

A new algorithm on lipid management and prevention of cardiovascular disease from the American Association of Clinical Endocrinologists* (AACE) and the American College of Endocrinology (ACE) is "a ...

American Association of Clinical Endocrinologists (AACE)Glenn Sebold, 904-353-7878 ext. 122 The American Association of Clinical Endocrinologists (AACE) today announced the online publication of the ...

In addition to BP control, early and intensive management of dyslipidemia is key to preventing macrovascular complications in T2D. The AACE recommends the following lipid targets for patients with T2D ...

diabetes obesity In January, 2016, the American Association of Clinical Endocrinologists/American College of Endocrinology (AAACE/ACE) released their 2016 Comprehensive Type 2 Diabetes Management ...